Skip to main content

Day: April 5, 2023

Securing Success: Key Approaches for Automotive Fastener Suppliers and Manufacturers

SkyQuest’s Automotive Fasteners market report is an excellent analysis for individuals interested in gaining insight into the valuable data, trends, and opportunities in a rapidly growing industry. Additionally, the report is written clearly and concisely, making it accessible to various audiences, from industry experts to market readers. Finally, one can gain an in-depth understanding of the primary and secondary market drivers, providing them with a comprehensive outlook of the current market situation and future projections. Westford, USA, April 05, 2023 (GLOBE NEWSWIRE) — SkyQuest projects that the Automotive Fasteners market will attain a value of USD 42.46 billion by 2030, with a CAGR of 5.77% over the forecast (2023-2030). The growth of the global market for automotive fasteners may be related to the increasing prevalence...

Continue reading

HighCo: Shareholding as 31/03/2023

INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES Declaration pursuant to Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulations of the Autorité des marchés financiers (AMF)Date of settlementof information Total number of shares Number of shares without voting rights (*) Number of voting rights for threshold calculation (**) Number of actual voting rights (exercisable at shareholders’ meeting)March 31, 2023 20 455 403 376 968 22 818 769 22 441 801February 28, 2023 20 455 403 319 981 22 818 769 22 498 788January 31, 2023 20 455 403 253 414 22 892 958 22 639 544December 31, 2022 20 455 403 250 392 22 948 713 22 698 321(*) exclusively consisting of treasury shares.(**) theoretical voting rights to calculate the threshold crossing including the voting right of treasury shares...

Continue reading

Intermex Completes La Nacional Acquisition of Non-U.S. Based Assets – LAN Holdings, Corp.

Intermex enters the European remittance market MIAMI, April 05, 2023 (GLOBE NEWSWIRE) — International Money Express, Inc. (NASDAQ: IMXI) (“Intermex” or the “Company”), a leading omnichannel money remittance services company, has completed its acquisition of LAN Holdings, Corp. (“LAN Holdings”). Through the purchase of LAN Holdings, Corp., Intermex also acquired I-Transfer Global Payments E.P., S.A.U., (“I-Transfer”), a Spain-based money transmitter that enables customers to send money transfers from Spain, Italy, and Germany. “We are excited to close on the international entities for the La Nacional acquisition which represent a tremendous opportunity for growth. Intermex will now provide outbound remittances from Spain, Italy, and Germany for the first time, and will expand its services and presence in Canada. The Company’s global...

Continue reading

NASDAQ-listed wealth and health firm, AGBA Group Holding Limited to acquire Sony Life Financial Advisers Pte Ltd in Singapore

AGBA Group signs agreement today to acquire Sony Life Financial Advisers Pte Ltd in Singapore Acquisition is a key milestone for AGBA’s business and expansion beyond the Greater Bay Area into Southeast AsiaHong Kong and Singapore, April 05, 2023 (GLOBE NEWSWIRE) — NASDAQ-listed AGBA Group Holding Limited “AGBA” today announced that it has entered into a sale and purchase agreement, dated 5 April 2023, to acquire Sony Life Financial Advisers Pte Ltd, a duly licensed financial adviser and insurance broker in Singapore. AGBA, together with its subsidiary, the “AGBA Group,” is a leading one-stop financial supermarket headquartered in Hong Kong. Trusted by over 400,000 individual and corporate customers, the AGBA Group offers the broadest set of financial services and healthcare products in the Greater Bay Area in China. The AGBA...

Continue reading

Avalon Acquisition Inc. Confirms Funding to Extend Period to Consummate Initial Business Combination

SAN FRANCISCO, April 05, 2023 (GLOBE NEWSWIRE) — Avalon Acquisition Inc. (the “Company,” “we” or “our”), a special purpose acquisition company, announced today that The Beneficient Company Group, L.P. (“BCG”) deposited an aggregate of $2,070,000 into the Company’s trust account for the Company’s public stockholders, representing $0.10 per public share, which enables us to extend the period of time we have to consummate our initial business combination by three months from April 8, 2023 to July 8, 2023 (the “Second Extension”). The Second Extension is the second of up to two three-month extensions permitted under the Company’s governing documents. We also received notice from our sponsor that our sponsor intends to effect the Second Extension, and our Board of Directors approved such Second Extension. As previously announced, on...

Continue reading

CytoDyn to Hold Webcast to Provide a Company Update

VANCOUVER, Washington, April 05, 2023 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Tanya Urbach, Board Chair, Cyrus Arman, President, Antonio Migliarese, Chief Financial Officer, and Scott Hansen, our newly appointed Head of Research and Basic Science, will host an investment community webcast to provide a Company update on Tuesday, April 11, 2023. Following the update, questions submitted prior to the webcast as directed below will be addressed to the extent appropriate.Date:     Tuesday, April 11, 2023Time:     1:00 pm PT / 4:00 pm ETAccess:     https://event.choruscall.com/mediaframe/webcast.html?webcastid=1VcOPtAYQuestions:     Please...

Continue reading

Systemic Bio™ Opens State-of-the-Art Laboratory for Bioprinted Organ-on-a-Chip R&D, Production to Accelerate Drug Discovery & Development

Systemic Bio Facility Grand Opening (L-R) 3D Systems President & CEO, Dr. Jeffrey Graves, Systemic Bio CEO, Taci Pereira, & 3D Systems EVP, Healthcare Solutions, Menno Ellis along with the Systemic Bio team at the ribbon cutting of their new headquarters.15,000 sq. ft. facility in TMC Innovation Factory Labs will house Systemic Bio’s R&D, production of patent-pending h-VIOS™ organ-on-a-chip platform Cleanroom manufacturing intended to support sterile production of thousands of h-VIOS chips, plates — an unprecedented capacity to support multiple contracts with pharmaceutical companies over next 12 months Jeremy Carter, seasoned biopharmaceutical production leader, joins as Vice President, Operations to oversee scaffold manufacturingHOUSTON, April 05, 2023 (GLOBE NEWSWIRE) — Today, Systemic Bio™,...

Continue reading

Duck Creek Technologies VP of Product Strategy and Co-Founder, Andy Yohn, to Present at the 2023 Verisk Insurance Conference

Boston, April 05, 2023 (GLOBE NEWSWIRE) — Duck Creek Technologies, the intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, is excited to announce that Andy Yohn, VP of Product Strategy and co-founder of Duck Creek, will be presenting with Verisk at the 2023 Verisk Insurance Conference in Scottsdale, AZ from April 11–14, 2023. Verisk will unite senior executives and professionals across the value chain to share significant insights, critical trends, and innovative solutions on insurance industry trends. In his session, Navigating the Noise: Dynamic & Actionable Data is Powering Automation in Small Commercial Insurance, Yohn will discuss how Artificial intelligence (AI), machine learning (ML) and computer vision can generate insights from unstructured data sources about...

Continue reading

RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders

Glen Rock, N.J., April 05, 2023 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, is pleased to announce the entering into a material transfer agreement with University College London (UCL) as part of a collaborative research effort involving Dr. Ian Coombs and Prof. Mark Farrant, founder members of the GRIA Scientific Advisory Board of the CureGRIN Foundation (“CureGRIN”) and from the UCL Department of Neuroscience, Physiology, and Pharmacology. The UCL group, which also includes Prof, Stuart Cull-Candy F.R.S., has been awarded funding from CureGRIN, and will be working with the RespireRx research team to study the possibility of...

Continue reading

Chocolate Confectionery Market to Hit USD 136.42 Billion by 2027 | Exhibiting a CAGR of 2.3%

Companies covered in chocolate confectionery market are Barry Callebaut (Zürich, Switzerland), Nestle S.A. (Vevey, Switzerland), Chocoladefabriken Lindt & Sprungli AG (Zürich, Switzerland), Ferrero SpA (Alba, Italy), HARIBO GmbH & Co. KG (Bonn, Germany), Mondelez International (Illinois, U.S.), Meiji Holdings Co., Ltd. (Tokyo, Japan), The Hershey Company (Pennsylvania, U.S.), Ezaki Glico Co., Ltd. (Osaka, Japan), Mars Inc. (Virginia, U.S.) Pune, India, April 05, 2023 (GLOBE NEWSWIRE) — The global chocolate confectionery market size is projected to reach USD 136.42 billion by 2027, exhibiting a CAGR of 2.3% during the forecast period. Widespread awareness regarding the potential health benefits of chocolate is expected to play a central role in driving the growth of this market, states Fortune Business Insights™...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.